Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Ferrous fumarate is a medication used to treat iron-deficiency anemia. Used in treatment of iron deficiency anemia.
- Mechanism
- Curator reviewed
Iron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.
- Primary indication
- Used in preventing and treating iron-deficiency anemia.Curator reviewed · 5 structured indications
- Formula / weight
- C4H2FeO4 · 169.901 g/mol (avg)
- First approval
- Canada, 1997 · United States, 2001
- Also known as
- iron fumarate · Iron(2+) fumarate
- Brand names
- Aurovela Fe
- Concept Ob
- Hailey Fe 1.5/30 28 Day
- Hematogen
- Microgestin Fe 1/20 28 Day
- Pregvit
- Tandem
- Tandem Plus
- Tarina 24 Fe 1/20 28 Day
Resolves to
Clinical / RWD
Structure
InChIKey
PMVSDNDAUGGCCE-TYYBGVCCSA-LSMILES[Fe++].[H]\C(=C(\[H])C([O-])=O)C([O-])=OWhat you can answer from here — as of May 03, 2025
13Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Ferrous fumarate, and which of those have an active Phase 3 trial?